PATENT CLAIM ANALYSIS

Application Number: 16177153
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["424", "186100"]

Abstract:
The present disclosure relates, in part, to pharmaceutical compositions comprising one or more polynucleotides suitable for enhancing, increasing, augmenting, and/or supplementing the levels of Collagen alpha-1 (VII) chain polypeptide and/or Lysyl hydroxylase 3 polypeptide and/or Keratin type I cytoskeletal 17 polypeptide in a subject. The present disclosure also relates, in part, to pharmaceutical compositions and methods of use for providing prophylactic, palliative, or therapeutic relief of a wound, disorder, or disease of the skin in a subject, including a subject having, or at risk of developing, one or more symptoms of epidermolysis bullosa.

Claim (Index 49):
The pharmaceutical composition of  claim 41 , wherein the subject is a human.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 97.0
- Lexical Diversity: 1.73438
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15393151', '15851488', '14905708', '10427739', '11166438']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8078615362805782
- 35 USC 102 Novelty (BERT): 0.6272373217126677
- Combined Prediction Score: 0.7897991148237872
- Mean Citation Score: 584.239466
- Max Citation Score: 951.2163
- Similarity Product: 525.0448502925933

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test